We intend to focus primarily on companies in the pharmaceutical, medical device, pharmaceutical and device outsourcing, healthcare technology, healthcare distribution and healthcare-related consumer sub-sectors. Avista Public Acquisition Corp. II intends to target companies believed to have scalable, protected products and services in non-cyclical sectors with expected long-term sustainable competitive advantages. (Incorporated in the  Cayman Islands)

Members of our management team are employees of Avista Capital Partners. Avista is a New York-based middle market private equity firm focused on control buyout and growth investments in the healthcare sector. Avista was founded in 2005 by Thompson Dean, our executive chairman, and David Burgstahler, our president, CEO and director. Avista’s founders have worked together for over 20 years.

(Note: Avista Public Acquisition Corp. II priced its SPAC IPO on Aug. 9, 2021, in sync with the terms in its prospectus: 20 million units at $10 each to raise $200 million.)